Impact of specialist care in patients with newly diagnosed heart failure
| ISRCTN | ISRCTN16302432 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN16302432 |
| Protocol serial number | N/A |
| Sponsor | Queens Medical Centre University Hospital (UK) |
| Funder | Local Delivery Plan for Heart Failure services in Nottingham (UK) |
- Submission date
- 20/07/2005
- Registration date
- 07/09/2005
- Last edited
- 08/09/2009
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr John Walsh
Scientific
Scientific
Department of Cardiovascular Medicine
Queens Medical Centre University Hospital
Nottingham
NG7 2UH
United Kingdom
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | Impact of specialist care in patients with newly diagnosed heart failure: a randomised controlled study |
| Study objectives | Out patients with newly diagnosed heart failure are managed more effectively when treated by specialists. |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Heart failure |
| Intervention | Management in a specialist heart failure clinic with regular follow up by heart failure nurses versus usual care. All patients were followed up for a minimum of 3 months post-randomisation with a mean follow-up time of 10+/-3 months |
| Intervention type | Other |
| Primary outcome measure(s) |
Optimum prescription of medication for heart failure including angiotensin-converting enzyme (ACE) inhibitors, Angiotensin receptor blockers, beta blockers and spironolactone. |
| Key secondary outcome measure(s) |
Composite endpoint of all cause mortality and/or hospitalisation. |
| Completion date | 06/09/2003 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | All |
| Target sample size at registration | 114 |
| Key inclusion criteria | Patients (adults, either sex) with suspected heart failure referred for an open access echocardiogram. |
| Key exclusion criteria | Patients with previously confirmed left ventricular systolic dysfunction on echo. |
| Date of first enrolment | 06/06/2002 |
| Date of final enrolment | 06/09/2003 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
Department of Cardiovascular Medicine
Nottingham
NG7 2UH
United Kingdom
NG7 2UH
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 07/02/2007 | Yes | No | |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
